HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H Michael Shepard Selected Research

H Michael Shepard Research Topics

Disease

22Neoplasms (Cancer)
01/2021 - 04/2002
4Breast Neoplasms (Breast Cancer)
11/2019 - 04/2002
3Pancreatic Neoplasms (Pancreatic Cancer)
10/2018 - 01/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2014 - 01/2009
3Arthritis (Polyarthritis)
01/2011 - 01/2008
2Multiple Sclerosis
01/2023 - 12/2018
2Hypoxia (Hypoxemia)
10/2018 - 01/2014
2Adenocarcinoma
01/2016 - 08/2015
2Experimental Arthritis
01/2011 - 10/2008
1Demyelinating Diseases (Demyelinating Disease)
01/2023
1Autoimmune Diseases (Autoimmune Disease)
01/2023
1Neoplasm Metastasis (Metastasis)
08/2015
1Fibrosis (Cirrhosis)
08/2015
1Squamous Cell Carcinoma of Head and Neck
02/2015
1Inflammation (Inflammations)
06/2014
1Necrosis
01/2011
1Hyperplasia
01/2008
1Rheumatoid Arthritis
01/2008
1Colonic Neoplasms (Colon Cancer)
04/2002
1Carcinoma (Carcinomatosis)
04/2002

Drug/Important Bio-Agent (IBA)

11Hyaluronic Acid (Hyaluronan)IBA
11/2019 - 11/2010
9PEGPH20IBA
11/2019 - 11/2010
8Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
11/2019 - 09/2012
5ErbB Receptors (EGF Receptor)IBA
01/2011 - 10/2008
4GlycosaminoglycansIBA
01/2014 - 11/2010
4Proteins (Proteins, Gene)FDA Link
01/2014 - 04/2002
4LigandsIBA
01/2011 - 01/2008
3EnzymesIBA
01/2021 - 04/2002
3Trastuzumab (Herceptin)FDA Link
10/2019 - 01/2011
3Monoclonal AntibodiesIBA
06/2017 - 11/2008
3Epidermal Growth Factor (EGF)IBA
01/2011 - 10/2008
2Chimeric Antigen ReceptorsIBA
12/2019 - 11/2019
2AntigensIBA
12/2019 - 11/2019
2Hyaluronan SynthasesIBA
11/2019 - 01/2014
2CollagenIBA
10/2018 - 08/2015
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
01/2015 - 01/2008
1AutoantigensIBA
01/2023
1Deoxycytidine KinaseIBA
01/2023
1Adenosine DeaminaseIBA
01/2021
1Adenosine (Adenocard)FDA LinkGeneric
01/2021
1Small Interfering RNA (siRNA)IBA
11/2019
1GlycopeptidesIBA
11/2019
1Biomarkers (Surrogate Marker)IBA
10/2019
1CytokinesIBA
10/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2018
1GemcitabineFDA Link
01/2016
1Cetuximab (Erbitux)FDA Link
02/2015
1Carrier Proteins (Binding Protein)IBA
01/2015
1EndotoxinsIBA
06/2014
1LipopolysaccharidesIBA
06/2014
1Cadherins (E-Cadherin)IBA
01/2014
1CateninsIBA
01/2014
1Etanercept (Enbrel)FDA Link
01/2011
1Colloids (Colloid)IBA
11/2010
1liposomal doxorubicin (Doxil)FDA Link
11/2010
1PolymersIBA
11/2010
1Proteoglycans (Proteoglycan)IBA
11/2010
1Docetaxel (Taxotere)FDA Link
11/2010
1Sequestering AgentsIBA
01/2009
1Tyrosine Kinase InhibitorsIBA
10/2008
1lysophosphatidic acidIBA
10/2008
1Tyrosine (L-Tyrosine)FDA Link
10/2008
1herstatinIBA
10/2008
1Cell Surface ReceptorsIBA
01/2008
1Messenger RNA (mRNA)IBA
01/2008
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2008
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2008
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2008
1NB1011IBA
04/2002
1Irinotecan (Camptosar)FDA LinkGeneric
04/2002
1Thymidylate SynthaseIBA
04/2002
1raltitrexed (D 1694)IBA
04/2002
1DNA (Deoxyribonucleic Acid)IBA
04/2002

Therapy/Procedure

11Therapeutics
01/2021 - 01/2008
2Immunotherapy
01/2021 - 02/2015
2Drug Therapy (Chemotherapy)
09/2012 - 11/2010
1Biological Therapy
01/2008